Literature DB >> 28643436

Emotional awareness and expression training improves irritable bowel syndrome: A randomized controlled trial.

E R Thakur1,2,3, H J Holmes1, N A Lockhart1, J N Carty1, M S Ziadni1, H K Doherty1, J M Lackner4, H Schubiner5, M A Lumley1.   

Abstract

BACKGROUND: Current clinical guidelines identify several psychological treatments for irritable bowel syndrome (IBS). IBS patients, however, have elevated trauma, life stress, relationship conflicts, and emotional avoidance, which few therapies directly target. We tested the effects of emotional awareness and expression training (EAET) compared to an evidence-based comparison condition-relaxation training-and a waitlist control condition.
METHODS: Adults with IBS (N=106; 80% female, Mean age=36 years) were randomized to EAET, relaxation training, or waitlist control. Both EAET and relaxation training were administered in three, weekly, 50-minute, individual sessions. All patients completed the IBS Symptom Severity Scale (primary outcome), IBS Quality of Life, and Brief Symptom Inventory (anxiety, depressive, and hostility symptoms) at pretreatment and at 2 weeks posttreatment and 10 weeks follow-up (primary endpoint). KEY
RESULTS: Compared to waitlist controls, EAET, but not relaxation training, significantly reduced IBS symptom severity at 10-week follow-up. Both EAET and relaxation training improved quality of life at follow-up. Finally, EAET did not reduce psychological symptoms, whereas relaxation training reduced depressive symptoms at follow-up (and anxiety symptoms at posttreatment). CONCLUSIONS & INFERENCES: Brief emotional awareness and expression training that targeted trauma and emotional conflicts reduced somatic symptoms and improved quality of life in patients with IBS. This emotion-focused approach may be considered an additional treatment option for IBS, although research should compare EAET to a full cognitive-behavioral protocol and determine which patients are best suited for each approach. Registered at clinicaltrials.gov (NCT01886027).
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  clinical trial; emotional expression; irritable bowel syndrome; relaxation

Mesh:

Year:  2017        PMID: 28643436      PMCID: PMC5690851          DOI: 10.1111/nmo.13143

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  37 in total

1.  Anger suppression, ironic processes and pain.

Authors:  Phillip J Quartana; K Lira Yoon; John W Burns
Journal:  J Behav Med       Date:  2007-08-22

2.  The therapeutic effect of adding emotional awareness training to standard medical treatment for irritable bowel syndrome: a randomized clinical trial.

Authors:  Alireza Farnam; Mohammad H Somi; Sara Farhang; Nafiseh Mahdavi; Mohammad Ali Besharat
Journal:  J Psychiatr Pract       Date:  2014-01       Impact factor: 1.325

3.  The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress.

Authors:  C Y Francis; J Morris; P J Whorwell
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

4.  Quality of life in persons with irritable bowel syndrome: development and validation of a new measure.

Authors:  D L Patrick; D A Drossman; I O Frederick; J DiCesare; K L Puder
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

5.  Expressive writing is a promising therapeutic modality for the management of IBS: a pilot study.

Authors:  Albena Halpert; Denis Rybin; Gheorghe Doros
Journal:  Am J Gastroenterol       Date:  2010-06-15       Impact factor: 10.864

6.  The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome.

Authors:  Francis Creed; Lakshmi Fernandes; Elspeth Guthrie; Stephen Palmer; Joy Ratcliffe; Nicholas Read; Christine Rigby; David Thompson; Barbara Tomenson
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

7.  The effects of a novel psychological attribution and emotional awareness and expression therapy for chronic musculoskeletal pain: A preliminary, uncontrolled trial.

Authors:  Amanda J Burger; Mark A Lumley; Jennifer N Carty; Deborah V Latsch; Elyse R Thakur; Maren E Hyde-Nolan; Alaa M Hijazi; Howard Schubiner
Journal:  J Psychosom Res       Date:  2015-12-11       Impact factor: 3.006

8.  Effects of therapeutically induced affect arousal on depressive symptoms, pain and beta-endorphins among rheumatoid arthritis patients.

Authors:  Larry E Beutler; Roger J Daldrup; David Engle; Elena M Oró-Beutler; Keith Meredith; John T Boyer
Journal:  Pain       Date:  1987-06       Impact factor: 6.961

9.  Gender differences in irritable bowel syndrome: the interpersonal connection.

Authors:  E R Thakur; M B Gurtman; L Keefer; D M Brenner; J M Lackner
Journal:  Neurogastroenterol Motil       Date:  2015-08-12       Impact factor: 3.598

10.  Posttraumatic stress disorder in female veterans: association with self-reported health problems and functional impairment.

Authors:  Dorcas J Dobie; Daniel R Kivlahan; Charles Maynard; Kristen R Bush; Tania M Davis; Katharine A Bradley
Journal:  Arch Intern Med       Date:  2004-02-23
View more
  18 in total

Review 1.  [Influence of early childhood stress exposure and traumatic life events on pain perception].

Authors:  J Tesarz; A Gerhardt; W Eich
Journal:  Schmerz       Date:  2018-08       Impact factor: 1.107

Review 2.  Emotional Awareness and Expression Therapy for Chronic Pain: Rationale, Principles and Techniques, Evidence, and Critical Review.

Authors:  Mark A Lumley; Howard Schubiner
Journal:  Curr Rheumatol Rep       Date:  2019-05-23       Impact factor: 4.592

3.  The Role of Gut-Brain Interactions in Influencing Symptoms of Irritable Bowel Syndrome.

Authors:  Emeran A Mayer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-01

Review 4.  Psychological Therapy for Centralized Pain: An Integrative Assessment and Treatment Model.

Authors:  Mark A Lumley; Howard Schubiner
Journal:  Psychosom Med       Date:  2019 Feb/Mar       Impact factor: 4.312

5.  Ambivalence over emotional expression and perceived social constraints as moderators of relaxation training and emotional awareness and expression training for irritable bowel syndrome.

Authors:  Hannah J Holmes; Elyse R Thakur; Jennifer N Carty; Maisa S Ziadni; Heather K Doherty; Nancy A Lockhart; Howard Schubiner; Mark A Lumley
Journal:  Gen Hosp Psychiatry       Date:  2018-05-03       Impact factor: 3.238

Review 6.  Emotion regulation as a transdiagnostic factor underlying co-occurring chronic pain and problematic opioid use.

Authors:  Rachel V Aaron; Patrick H Finan; Stephen T Wegener; Francis J Keefe; Mark A Lumley
Journal:  Am Psychol       Date:  2020-09

7.  A life-stress, emotional awareness, and expression interview for primary care patients with medically unexplained symptoms: A randomized controlled trial.

Authors:  Maisa S Ziadni; Jennifer N Carty; Heather K Doherty; John H Porcerelli; Lisa J Rapport; Howard Schubiner; Mark A Lumley
Journal:  Health Psychol       Date:  2017-11-20       Impact factor: 4.267

8.  Effects of a comprehensive self-management intervention on extraintestinal symptoms among patients with IBS.

Authors:  Kendra J Kamp; Kristen R Weaver; LeeAnne B Sherwin; Pamela Barney; Sun-Kyung Hwang; Pei-Lin Yang; Robert L Burr; Kevin C Cain; Margaret M Heitkemper
Journal:  J Psychosom Res       Date:  2019-08-29       Impact factor: 3.006

9.  The Effects of a Life Stress Emotional Awareness and Expression Interview for Women with Chronic Urogenital Pain: A Randomized Controlled Trial.

Authors:  Jennifer N Carty; Maisa S Ziadni; Hannah J Holmes; Janice Tomakowsky; Kenneth Peters; Howard Schubiner; Mark A Lumley
Journal:  Pain Med       Date:  2019-07-01       Impact factor: 3.750

Review 10.  Emotional awareness and other emotional processes: implications for the assessment and treatment of chronic pain.

Authors:  Mark A Lumley; Shoshana Krohner; Liyah M Marshall; Torran C Kitts; Howard Schubiner; Brandon C Yarns
Journal:  Pain Manag       Date:  2021-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.